Additional Subject Matter

MBF Bioscience >  Blog > Additional Subject Matter (Page 12)

No two neurons are exactly alike. Structure dictates function, so for scientists to fully understand the way different types of neurons work, they must first get to know their forms.   Scientists at the Institute for Neuroscience and Medicine at the Research Center Jülich in Jülich, Germany use Neurolucida to perform neuron reconstruction, the most effective method for studying neuron morphology.   In their paper “Improved biocytin labeling and...

Read More

Neurotrophic factors may be the key to the cure for Parkinson’s, Huntington's, Alzheimer's, and other neurodegenerative disorders. Scientists have known this for over twenty years. But the question continues to loom – how does one safely and effectively deliver the neurotrophic factors to the damaged neurons? Dr. Raymond Bartus and his team at Ceregene, a biotechnology company in San Diego, have developed an innovative approach...

Read More

  Some children raised in orphanages grow up to develop social disorders, and there's not all that much modern medicine can do about it. But scientists at Harvard Medical School are working on gaining a better understanding of how early isolation affects a developing brain. Their research gives new insight into the mechanisms at play, and indicates that timing and healthy myelination are crucial.   “Social isolation from...

Read More

  A baby cries and her mother's maternal instincts kick in. She picks her baby up, rocks her, feeds her. Changes in a new mother's brain compel her to act in ways that ensure her baby's survival. Researchers at the Hebrew University of Jerusalem are working on learning more about those changes. Their recent focus is on the olfactory bulb – a region of the brain...

Read More

MBF Bioscience was featured in an episode of Emerging Science,  a television series that features Vermont scientists who expand human knowledge and help solve problems around the world.   The episode explored the link between traumatic brain injury and post traumatic stress disorder in military personnel coming back from war.   MBF Bioscience President Jack Glaser and Staff Scientist Susan Hendricks give us some perspective from a research standpoint...

Read More

Long-time MBF customers at the University of Rochester Medical Center are considered leading experts in researching myelin diseases. They recently published a review article in Science titled “Glial Progenitor Cell-Based treatment and Modeling of Neurological Disease” in which they featured output from Stereo Investigator in the Figure 2 section to illustrate chimeric brains. {Glial Progenitor Cell–Based Treatment and Modeling of Neurological Disease Steven A. Goldman, Maiken Nedergaard, and Martha S....

Read More

Approximately 11,000 Americans become paralyzed from spinal cord injuries each year with little hope for recovery. But new research from the University of California at San Diego saw some promising results.   The research team, led by MBF Bioscience customer Dr. Mark Tuszynski and Dr. Paul Lu saw movement in paralyzed rats after grafting a gel containing neural stem cells to the rats' injured spinal cords. According...

Read More

When it comes to preferred neuron reconstruction systems, Neurolucida “dominated the last decade” according to a paper published earlier this year in Frontiers in Neuroscience. The paper, “Digital reconstructions of neuronal morphology: three decades of research trends" (Halavi et al, 2012), offers an overview of the history of digital neuron reconstruction and presents research trends on specific animal species, brain regions, neuron types, and experimental approaches. Beginning...

Read More

In the early 1960s, our company co-founder Dr. Edmund Glaser and his long time collaborator and friend Dr. Hendrik Van der Loos made some sketches on a paper tablecloth in the faculty dining room at John Hopkins Hospital, in Baltimore Maryland. That early diagram of a microscope included novel elements like transducers and a mechanical stage, and gave shape to their ideas about a faster way...

Read More

Blue Brain Project researchers have hit an important milestone in their quest to create a virtual model of the human brain. They figured out how to accurately predict the location of synapses in the neocortex; and Neurolucida played an important part.   In a paper published last week in PNAS, the research team led by Dr. Henry Markram at the Brain Mind Institute at the Ecole Polytechnique Fédérale...

Read More